2023 Fall/Winter Highlights of Hope

More documents

Recommendations

Info

RESEARCH Generosity of VAI employees empowers osteoporosis discovery What started as a question about an odd bone could one day lead to new ways to treat osteoporosis with fewer side effects, thanks to a collaborative team of inquisitive scientists fueled by philanthropic funding from VAI employees. The discovery, published earlier this year in the journal Science Advances, identified a protein called KDM5C as a potential treatment target for osteoporosis. It also shed new light on how and why women lose bone mass as they age, a process that results in nearly one in five women facing osteoporosis after age 50. The findings offer new hope for improved osteoporosis treatments and underscore the importance of innovation, a shared spirit of collaboration and the value of asking a simple question: why? Funny bones and curious questions Postdoctoral fellow Dr. Lukai Zhai couldn’t shake the feeling that something was off about the tiny piece of bone he was studying in the lab. It appeared denser than it should. Zhai was intrigued, so he reached out to Dr. Huadie Liu, a postdoctoral fellow who studies bone diseases. Together with their mentors — Dr. Connie Krawczyk and Dr. Tao Yang — they came up with an idea. What if the protein Zhai studied, KDM5C, had something to do with the bone changes? The prospect was an exciting one. KDM5C is an epigenetic modulator — a fancy term for molecular helper that ensures the instructions in DNA are carried out correctly. It works by altering epigenetic marks, which are akin to “on” and “off” switches that enable our genetic instructions to be used at the right time and in the right place. KDM5C is also associated with X chromosomes, meaning it is more active in women than in men. Because of this, disorders linked to KDM5C are much more prevalent in women — a common thread shared with osteoporosis. This connection offered a tantalizing clue that the team was on the right track. The Krawczyk and Yang labs had a compelling question. Now, they needed support to make the project happen. A team effort Enter VAI’s Employee Impact Campaign, a fund sustained by the generosity of Institute employees. Once a year, VAI scientists and educators pitch their ideas to employee-donors, who then vote on which projects to support. DR. CONNIE KRAWCZYK DR. HUADIE LIU 4 | VAN ANDEL INSTITUTE HIGHLIGHTS OF HOPE
The fund gives fledgling research projects the springboard they need to get off the ground and gather the early data required to secure subsequent grant funding. In 2021, VAI employees voted to award Yang and Krawczyk nearly $73,000 for the project. This funding enabled their teams to investigate differences in the way bone is regulated in male and female mice, which share many similarities with humans and are important models for studying health and disease. “The Employee Impact Campaign fosters collaborative research across disciplines and enables research that couldn’t happen in just one lab,” Yang said. “It’s a tremendous program that allows everyone to contribute to science, no matter their role at VAI. We are so grateful to our colleagues for supporting our work.” “Lowering KDM5C levels is like flipping a switch to stop an overactive recycling process. The result is greater bone density, which ultimately means stronger bones,” Krawczyk said. “We’re very excited about this work and look forward to carrying out future studies to refine our findings. At the end of the day, we hope these insights make a difference for people with osteoporosis.” Funding Acknowledgement Research reported in this publication was supported by Van Andel Institute; Van Andel Institute’s Employee Impact Campaign; and the National Institute on Aging of the National Institutes of Health under award no. R01AG061086 (Yang). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or other funding organizations. As part of their project, the Krawczyk and Yang labs focused on specialized cells called osteoclasts, which help maintain bone health by breaking down and recycling old bone. They discovered that reducing KDM5C disrupted cellular energy production in osteoclasts, which slowed down the recycling process and preserved bone mass. DR. TAO YANG DR. LUKAI ZHAI VAN ANDEL INSTITUTE HIGHLIGHTS OF HOPE | 5
Page 1 and 2: HIGHLIGHTS OF HOPE FALL/WINTER ’2
Page 3: How a new discovery may inform futu
Page 7 and 8: Working together for a cure: VAI, C
Page 9 and 10: Student-drawn neon renderings of ce
Page 11 and 12: VAN ANDEL INSTITUTE HIGHLIGHTS OF H
Page 13 and 14: Bladder inflammation from UTIs may
Page 19 and 20: To date, scientists in VAI’s Depa
Page 21 and 22: Earlycareer scientists earn accolad
Page 23 and 24: Flexible learning options for today
Page 25 and 26: “We saw these events that weren
Page 27 and 28: “These gatherings help keep the I
Page 29 and 30: Around the World The official kicko
Page 31 and 32: Fash Forward with Max Mara: Spring/
Page 33 and 34: (STARTING AT TOP LEFT, GOING CLOCKW
Page 35 and 36: Curiosity Hour: Out of This World S
Page 39 and 40: Theresa Drost Casey Jankoska Carol
Page 41 and 42: David Sowerby Anonymous Scott & Nic

2023 Fall/Winter Highlights of Hope

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?